Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.
ncRNA name
CircMED27
Specific or universal ncRNAs
Specific ncRNAs
Class
Circular RNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
Not available
Cancer name
Hepatocellular Carcinoma
Cancer site
qRT-PCR,Western blot
Treatment type
Chemotherapy
Drug
Lenvatinib
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
circRNA circMED27 acts as a prognostic factor and mediator to promote lenvatinib resistance of hepatocellular carcinoma
Tissue resource
Clinical tissue samples and healthy donor samples
hepatocellular carcinoma cell lines Hep3B
hepatocellular carcinoma cell lines Huh7
hepatocellular carcinoma cell lines HepG2
hepatocellular carcinoma cell lines SK-Hep-1
hepatocellular carcinoma cell lines PLC/PRF/5
Experiment
None
Institute
Shanghai Cancer Center,Fudan University
the Chinese Academy of Science Cell Bank
Country
China
China
Continent
Asia
Asia
Asia
Asia
Asia
Asia
Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.